Cong Long-Long, Cai Zhi-Qiang, Guo Peng, Chen Chen, Liu De-Chun, Li Wen-Zhi, Wang Lin, Zhao Yaling, Si Shu-Bin, Geng Zhi-Min
Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Department of Industrial Engineering, School of Mechanical Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
J Surg Oncol. 2017 Dec;116(8):1123-1131. doi: 10.1002/jso.24797. Epub 2017 Sep 6.
To determine whether radical resection can benefit patients with advanced gallbladder adenocarcinoma using a Bayesian network (BN) with clinical data.
In total, 362 patients who had undergone surgical treatment of gallbladder adenocarcinoma at a tertiary institute were evaluated to establish two BN models using a tree-augmented naïve Bayes algorithm. We then chose 250 patients with T3-4N0-2M0 stage gallbladder adenocarcinoma to test the posterior probability after the surgical type was taken into account.
In total, 170 patients (≤7 months) and 137 patients (>7 months) were correctly classified in the median survival time model (accuracy, 84.81%), and 204 patients (≤12 months), 15 patients (12-36 months), 17 patients (36-60 months), and 34 patients (>60 months) were correctly classified in the 1-, 3-, and 5-year survival model (accuracy, 74.59%), respectively. Every posterior probability in the two models upregulated the ratio of the longer survival time and suggested a better prognosis for gallbladder adenocarcinoma that can be improved by R0 resection.
These BN models indicate that stages T4 and N2 gallbladder adenocarcinoma are not contraindications for surgery and that R0 resection can improve survival in patients with advanced gallbladder adenocarcinoma.
利用贝叶斯网络(BN)及临床数据,确定根治性切除术是否能使晚期胆囊腺癌患者获益。
对一家三级医疗机构中362例行胆囊腺癌手术治疗的患者进行评估,采用树增强朴素贝叶斯算法建立两个BN模型。然后选取250例T3-4N0-2M0期胆囊腺癌患者,在考虑手术类型后测试后验概率。
中位生存时间模型中,分别有170例(≤7个月)和137例(>7个月)患者被正确分类(准确率84.81%);1年、3年和5年生存模型中,分别有204例(≤12个月)、15例(12 - 36个月)、17例(36 - 60个月)和34例(>60个月)患者被正确分类(准确率分别为74.59%)。两个模型中的每个后验概率均上调了较长生存时间的比例,并提示R0切除可改善胆囊腺癌患者的预后。
这些BN模型表明,T4期和N2期胆囊腺癌并非手术禁忌证,R0切除可提高晚期胆囊腺癌患者的生存率。